Significant Ownership of Five Narrow Lane LP

Signature - Title
/s/ Arie Rabinowitz - Arie Rabinowitz/Managing Member of the General Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Five Narrow Lane LP.

Follow Filing Activity

Follow Five Narrow Lane LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Five Narrow Lane LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ATAK DIH HOLDING US, INC. COMMON STOCK 10% $23,579,166 4,697,045 Five Narrow Lane LP 03 Feb 2025
GTBP GT BIOPHARMA, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 10% $552,386 253,388 Five Narrow Lane LP 13 May 2025
NAYA NAYA BIOSCIENCE INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE 10% $233,664 708,074 Five Narrow Lane LP 14 Jan 2025
OGEN ORAGENICS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 10% 82,210 Five Narrow Lane LP 02 Jul 2025
ALOY REALLOYS INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 5% $27,814,665 -$27,873,521 2,849,688 -50% Five Narrow Lane LP 26 Mar 2026
SMTK SMARTKEM INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 4.7% $416,421 -$178,924 287,187 -30% Five Narrow Lane LP 31 Dec 2025
BLBX BLACKBOXSTOCKS INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 1.2% $289,103 -$849,354 48,835 -75% Five Narrow Lane LP 30 Sep 2025
IVF INVO FERTILITY, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE 0.29% $5,687 6,935 Five Narrow Lane LP 20 Jan 2026

Schedules 13D/G Reported by Five Narrow Lane LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .